ADRA1B Antikörper (1st Cytoplasmic Domain)
Kurzübersicht für ADRA1B Antikörper (1st Cytoplasmic Domain) (ABIN1731572)
Target
Alle ADRA1B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- 1st Cytoplasmic Domain
-
Spezifität
- Reacts with human ADRA1B
-
Kreuzreaktivität (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins, except SLC22A3 (50 % ).
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Synthetic 16 amino acid peptide from 1st cytoplasmic domain of human ADRA1B. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Marmoset (100%), Bovine (94%), Monkey (88%), Mouse (88%), Rat (88%), Hamster (88%)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: IHC - P (6 μg/mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-80 °C
-
Informationen zur Lagerung
- Long term: -70°C, Short term: +4°C
-
-
- ADRA1B (Adrenergic, alpha-1B-, Receptor (ADRA1B))
-
Andere Bezeichnung
- ADRA1B
-
Hintergrund
- This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine (PE)-stimulated ERK signaling in cardiac myocytes
-
UniProt
- P35368
-
Pathways
- AMPK Signaling, Carbohydrate Homeostasis, Regulation of Carbohydrate Metabolic Process
Target
-